Related / Contacts
Related / News
Biogen Idec and Sobi to donate 1 billion international units of clotting factor to support treatment of haemophilia in developing world
Press Releases • May 12, 2014 07:00 GMT
Biogen Idec and Sobi today announced their intent to produce one billion international units of clotting factor therapy for humanitarian aid programs in the developing world at the World Federation of Hemophilia 2014 World Congress.
Press Releases • Oct 12, 2015 11:37 GMT
World Federation of Hemophilia announces expansion of humanitarian aid programme. Biogen, Sobi and the World Federation of Hemophilia collaboration to enable a sustained humanitarian supply of haemophilia treatment with the potential to change treatment paradigm in developing countries.